+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vaccine Development"

Middle East & Africa Vaccines Market Outlook, 2028 - Product Thumbnail Image

Middle East & Africa Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 87 Pages
  • Africa, Middle East
From
Asia-Pacific Vaccines Market Outlook, 2028 - Product Thumbnail Image

Asia-Pacific Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 107 Pages
  • Asia Pacific
From
North America Vaccines Market Outlook, 2028 - Product Thumbnail Image

North America Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 101 Pages
  • North America
From
Vaccines Market Outlook, 2028 - Product Thumbnail Image

Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 194 Pages
  • Global
From
From
RNA Vaccine Patent Landscape 2021 - Product Thumbnail Image

RNA Vaccine Patent Landscape 2021

  • Report
  • January 2021
  • 109 Pages
  • Global
Vaccines Market Access in Emerging Markets - Product Thumbnail Image

Vaccines Market Access in Emerging Markets

  • Report
  • August 2019
  • 76 Pages
  • Global
From
From
From
From
Loading Indicator

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise. The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more